Alerts will be sent to your verified email
Verify Email
PGHL
|
Procter&Gamble Healt
|
Strides Pharma Scien
|
Marksans Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
20.1 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
30.46 % | -4.18 % | 18.16 % |
|
5yr average Equity Multiplier
|
2.99 | 2.64 | 1.35 |
|
5yr Average Asset Turnover Ratio
|
0.57 | 0.54 | 0.99 |
|
5yr Avg Net Profit Margin
|
17.93 % | -2.56 % | 13.73 % |
|
Price to Book
|
18.31 | 3.25 | 4.63 |
|
P/E
|
39.14 | 2.31 | 30.04 |
|
5yr Avg Cash Conversion Cycle
|
-158.56 Days | -66.38 Days | 69.54 Days |
|
Inventory Days
|
36.98 Days | 69.16 Days | 87.55 Days |
|
Days Receivable
|
29.14 Days | 71.28 Days | 69.35 Days |
|
Days Payable
|
177.2 Days | 248.23 Days | 84.4 Days |
|
5yr Average Interest Coverage Ratio
|
337.3 | 0.41 | 32.98 |
|
5yr Avg ROCE
|
19.93 % | 9.77 % | 23.15 % |
|
5yr Avg Operating Profit Margin
|
24.91 % | 13.1 % | 19.67 % |
|
5 yr average Debt to Equity
|
0.0 | 1.02 | 0.02 |
|
5yr CAGR Net Profit
|
-4.58 % | n/a | 21.8 % |
|
5yr Average Return on Assets
|
10.24 % | -1.34 % | 13.43 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.82 % | 28.3 % | 43.87 % |
|
Share Pledged by Promoters
|
0.0 | 51.98 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.3 % | -4.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
4.1 % | -3.5 % | 2.91 % |
|
Procter&Gamble Healt
|
Strides Pharma Scien
|
Marksans Pharma
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|